Insider Trading & Ownership of Astrid Borkowski

Location
Boston, MA
Summary
The estimated net worth of Astrid Borkowski is at least $3,208,660 dollars as of 12 Feb 2024. Astrid Borkowski is the Chief Medical Officer of HilleVax, Inc. and owns shares of HilleVax, Inc. stock worth about $3.21M.
Signature
/s/ Paul Bavier, Attorney-in-Fact for Astrid Borkowski
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow Astrid Borkowski and return when a new Insider Trading filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.

Quick Takeaways

  • Astrid Borkowski has 1 issuer position tracked on this page.
  • Estimated disclosed ownership value: $3,208,660.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: HilleVax, Inc. ($3,208,660).
  • Past-year value change for that position: .

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Source Evidence

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Astrid Borkowski

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
HLVX HilleVax, Inc. Chief Medical Officer $3,208,660 08 Feb 2024

Insider Transactions Reported by Astrid Borkowski:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .